ESC 365 - Newly emerging data from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial: a principal investigator’s perspective.

ESC Premium Access

Newly emerging data from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial: a principal investigator’s perspective.

Session: Emerging insights from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial

Topic: Diabetes management

Speaker: Doctor E. Peterson (Dallas, US)

Sponsored by MSD

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Eric Peterson

UT Southwestern Medical Center, Dallas (United States of America)

15 presentations

0 follower

1 more presentation in this session

Open Q&A - Emerging insights from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial.

Speaker: Doctor E. Peterson (Dallas, US)

Access the full session

Emerging insights from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial

Speakers: Doctor E. Peterson, Doctor E. Peterson

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources